KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Debt Ratio (2017 - 2020)

Historic Debt Ratio for Xenon Pharmaceuticals (XENE) over the last 4 years, with Q1 2020 value amounting to 0.13.

  • Xenon Pharmaceuticals' Debt Ratio rose 7.74% to 0.13 in Q1 2020 from the same period last year, while for Mar 2020 it was 0.13, marking a year-over-year increase of 7.74%. This contributed to the annual value of 0.11 for FY2019, which is N/A changed from last year.
  • Xenon Pharmaceuticals' Debt Ratio amounted to 0.13 in Q1 2020, which was up 7.74% from 0.11 recorded in Q4 2019.
  • Xenon Pharmaceuticals' Debt Ratio's 5-year high stood at 0.18 during Q1 2018, with a 5-year trough of 0.11 in Q4 2019.
  • Moreover, its 4-year median value for Debt Ratio was 0.14 (2019), whereas its average is 0.14.
  • Within the past 5 years, the most significant YoY rise in Xenon Pharmaceuticals' Debt Ratio was 3647.28% (2019), while the steepest drop was 2741.93% (2019).
  • Over the past 4 years, Xenon Pharmaceuticals' Debt Ratio (Quarter) stood at 0.15 in 2017, then fell by 22.65% to 0.11 in 2018, then decreased by 7.8% to 0.11 in 2019, then increased by 25.71% to 0.13 in 2020.
  • Its Debt Ratio stands at 0.13 for Q1 2020, versus 0.11 for Q4 2019 and 0.16 for Q3 2019.